Business
Press Release Apr 01 2021
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2021, titled "Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited, receives USFDA Final Approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/gram".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2021, titled \"Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited, receives USFDA Final Approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/gram\". View Attachment","length":515,"tagName":"div"}]